Apoptin enhances the oncolytic properties of vaccinia virus and modifies mechanisms of tumor regression

A recombinant vaccinia virus VVdGF-ApoS24/2 expressing apoptin selectively kills human cancer cells in vitro [Kochneva et al., 2013]. We compared the oncolytic activity of this recombinant with that of the parental strain L-IVP using a model of human A431 carcinoma xenografts in nude mice. Single in...

Descripción completa

Detalles Bibliográficos
Autores principales: Kochneva, Galina, Zonov, Evgeniy, Grazhdantseva, Antonina, Yunusova, Anastasiya, Sibolobova, Galina, Popov, Evgeniy, Taranov, Oleg, Netesov, Sergei, Chumakov, Peter, Ryabchikova, Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4294355/
https://www.ncbi.nlm.nih.gov/pubmed/25358248

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4294355/
https://www.ncbi.nlm.nih.gov/pubmed/25358248

Ejemplares similares